Abstract
Background Vascular calcification is common and associated with unfavorable outcomes among patients with end-stage renal disease (ESRD). Nevertheless, little is known whether the progression of vascular calcification outweighs the baseline calcification in association with overall and cardiovascular (CV) mortality in hemodialysis (HD) patients. Methods This study included 140 maintenance HD patients. Vascular calcification was assessed using the aortic arch calcification (AoAC) score measured from chest radiographs at the baseline and the second year of follow-up. Progression of vascular calcification (ΔAoAC) was defined as the difference between the two measurements of AoAC. The association of ΔAoAC with overall and CV mortality was evaluated using multivariate Cox regression analysis. Results During the mean follow-up period of 5.8 years, there were 49 (35%) overall mortality and 27 (19.3%) CV mortality. High brachial-ankle pulse wave velocity was positively correlated with ΔAoAC, whereas old age was negatively correlated with ΔAoAC. In multivariate adjusted Cox analysis, increased ΔAoAC (per 1 unit), but not baseline AoAC, was significantly associated with overall mortality (HR, 1.183; 95% CI, 1.056–1.327; p = 0.004) and CV mortality (HR, 1.194; 95% CI, 1.019–1.398; p = 0.028). Conclusion Progression of AoAC outperformed the baseline AoAC in association with increased risk of overall and CV mortality in HD patients. A regular follow-up of chest radiograph and AoAC score assessments are simple and cost-effective to identify the high-risk individuals of unfavorable outcomes in maintenance HD patients.
Highlights
Advances in pharmaceutical and imaging technology improve precision of disease treatment and diagnosis, cardiovascular (CV) disease remains the major cause of morbidity and mortality among patients with end-stage renal disease (ESRD) [1,2,3]
Age (unstandardized coefficient β, 0.175; 95% confidence interval (CI), 0.112–0.238; p < 0:001), pulse pressure, HD vintage, calciumphosphate product, and intact parathyroid hormone (iPTH) were positively correlated with baseline aortic arch calcification (AoAC)
Lee et al demonstrated that the progression of AoAC at a 1-year interval is significantly associated with increased mortality among patients on peritoneal dialysis [16]
Summary
Advances in pharmaceutical and imaging technology improve precision of disease treatment and diagnosis, cardiovascular (CV) disease remains the major cause of morbidity and mortality among patients with end-stage renal disease (ESRD) [1,2,3]. The aortic arch calcification (AoAC) score is a simple, noninvasive, and semiquantitative assessment for evaluation of vascular calcification by chest radiograph [18]. It is highly correlated with the AoAC volume as determined by multidetector CT [18]. Vascular calcification is common and associated with unfavorable outcomes among patients with end-stage renal disease (ESRD). Vascular calcification was assessed using the aortic arch calcification (AoAC) score measured from chest radiographs at the baseline and the second year of follow-up. A regular follow-up of chest radiograph and AoAC score assessments are simple and cost-effective to identify the high-risk individuals of unfavorable outcomes in maintenance HD patients
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
